Global Influenza Virus Vaccine (H1N1) Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 91
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Intramuscular Vaccine

- Nasal Spray Vaccine

Segment by Application

- 3 To 10 Years Old

- 10 To 18 Years Old

- Above 18 Years Old

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- CSL

- NVS(Novartis)

- Sanofi Pasteur

- Medimmune

- GSK

- Baxter

- Beijing Kexing Bio-Vaccine

- Hualan Bio-Vaccine

- Changchun Changsheng Bio-Technology

- Beijing Tiantan Bio-Products

- Jiangsu Yanshen Bio-Technology

- Zhejiang Tianyuan Bio-Pharmaceutical

- Dalian Yalifeng Bio-Pharmaceutical

- Sinopharm

Global Influenza Virus Vaccine (H1N1) Market Research Report 2022

Table of Contents
1 Influenza Virus Vaccine (H1N1) Market Overview
1.1 Product Overview and Scope of Influenza Virus Vaccine (H1N1)
1.2 Influenza Virus Vaccine (H1N1) Segment by Type
1.2.1 Global Influenza Virus Vaccine (H1N1) Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Intramuscular Vaccine
1.2.3 Nasal Spray Vaccine
1.3 Influenza Virus Vaccine (H1N1) Segment by Application
1.3.1 Global Influenza Virus Vaccine (H1N1) Sales Comparison by Application: (2022-2028)
1.3.2 3 To 10 Years Old
1.3.3 10 To 18 Years Old
1.3.4 Above 18 Years Old
1.3.5 Other
1.4 Global Influenza Virus Vaccine (H1N1) Market Size Estimates and Forecasts
1.4.1 Global Influenza Virus Vaccine (H1N1) Revenue 2017-2028
1.4.2 Global Influenza Virus Vaccine (H1N1) Sales 2017-2028
1.4.3 Influenza Virus Vaccine (H1N1) Market Size by Region: 2017 Versus 2021 Versus 2028
2 Influenza Virus Vaccine (H1N1) Market Competition by Manufacturers
2.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturers (2017-2022)
2.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Influenza Virus Vaccine (H1N1) Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Influenza Virus Vaccine (H1N1) Manufacturing Sites, Area Served, Product Type
2.5 Influenza Virus Vaccine (H1N1) Market Competitive Situation and Trends
2.5.1 Influenza Virus Vaccine (H1N1) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Influenza Virus Vaccine (H1N1) Players Market Share by Revenue
2.5.3 Global Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Influenza Virus Vaccine (H1N1) Retrospective Market Scenario by Region
3.1 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
3.3.1 North America Influenza Virus Vaccine (H1N1) Sales by Country
3.3.2 North America Influenza Virus Vaccine (H1N1) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
3.4.1 Europe Influenza Virus Vaccine (H1N1) Sales by Country
3.4.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Influenza Virus Vaccine (H1N1) Market Facts & Figures by Region
3.5.1 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region
3.5.2 Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
3.6.1 Latin America Influenza Virus Vaccine (H1N1) Sales by Country
3.6.2 Latin America Influenza Virus Vaccine (H1N1) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
3.7.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country
3.7.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Influenza Virus Vaccine (H1N1) Historic Market Analysis by Type
4.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2022)
4.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2017-2022)
4.3 Global Influenza Virus Vaccine (H1N1) Price by Type (2017-2022)
5 Global Influenza Virus Vaccine (H1N1) Historic Market Analysis by Application
5.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2022)
5.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2017-2022)
5.3 Global Influenza Virus Vaccine (H1N1) Price by Application (2017-2022)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2017-2022)
6.1.4 CSL Influenza Virus Vaccine (H1N1) Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 NVS(Novartis)
6.2.1 NVS(Novartis) Corporation Information
6.2.2 NVS(Novartis) Description and Business Overview
6.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2017-2022)
6.2.4 NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Portfolio
6.2.5 NVS(Novartis) Recent Developments/Updates
6.3 Sanofi Pasteur
6.3.1 Sanofi Pasteur Corporation Information
6.3.2 Sanofi Pasteur Description and Business Overview
6.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Portfolio
6.3.5 Sanofi Pasteur Recent Developments/Updates
6.4 Medimmune
6.4.1 Medimmune Corporation Information
6.4.2 Medimmune Description and Business Overview
6.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Medimmune Influenza Virus Vaccine (H1N1) Product Portfolio
6.4.5 Medimmune Recent Developments/Updates
6.5 GSK
6.5.1 GSK Corporation Information
6.5.2 GSK Description and Business Overview
6.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2017-2022)
6.5.4 GSK Influenza Virus Vaccine (H1N1) Product Portfolio
6.5.5 GSK Recent Developments/Updates
6.6 Baxter
6.6.1 Baxter Corporation Information
6.6.2 Baxter Description and Business Overview
6.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Baxter Influenza Virus Vaccine (H1N1) Product Portfolio
6.6.5 Baxter Recent Developments/Updates
6.7 Beijing Kexing Bio-Vaccine
6.6.1 Beijing Kexing Bio-Vaccine Corporation Information
6.6.2 Beijing Kexing Bio-Vaccine Description and Business Overview
6.6.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Portfolio
6.7.5 Beijing Kexing Bio-Vaccine Recent Developments/Updates
6.8 Hualan Bio-Vaccine
6.8.1 Hualan Bio-Vaccine Corporation Information
6.8.2 Hualan Bio-Vaccine Description and Business Overview
6.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Portfolio
6.8.5 Hualan Bio-Vaccine Recent Developments/Updates
6.9 Changchun Changsheng Bio-Technology
6.9.1 Changchun Changsheng Bio-Technology Corporation Information
6.9.2 Changchun Changsheng Bio-Technology Description and Business Overview
6.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Portfolio
6.9.5 Changchun Changsheng Bio-Technology Recent Developments/Updates
6.10 Beijing Tiantan Bio-Products
6.10.1 Beijing Tiantan Bio-Products Corporation Information
6.10.2 Beijing Tiantan Bio-Products Description and Business Overview
6.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Portfolio
6.10.5 Beijing Tiantan Bio-Products Recent Developments/Updates
6.11 Jiangsu Yanshen Bio-Technology
6.11.1 Jiangsu Yanshen Bio-Technology Corporation Information
6.11.2 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Description and Business Overview
6.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Portfolio
6.11.5 Jiangsu Yanshen Bio-Technology Recent Developments/Updates
6.12 Zhejiang Tianyuan Bio-Pharmaceutical
6.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
6.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Description and Business Overview
6.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Portfolio
6.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments/Updates
6.13 Dalian Yalifeng Bio-Pharmaceutical
6.13.1 Dalian Yalifeng Bio-Pharmaceutical Corporation Information
6.13.2 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Description and Business Overview
6.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Portfolio
6.13.5 Dalian Yalifeng Bio-Pharmaceutical Recent Developments/Updates
6.14 Sinopharm
6.14.1 Sinopharm Corporation Information
6.14.2 Sinopharm Influenza Virus Vaccine (H1N1) Description and Business Overview
6.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Sinopharm Influenza Virus Vaccine (H1N1) Product Portfolio
6.14.5 Sinopharm Recent Developments/Updates
7 Influenza Virus Vaccine (H1N1) Manufacturing Cost Analysis
7.1 Influenza Virus Vaccine (H1N1) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1)
7.4 Influenza Virus Vaccine (H1N1) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Influenza Virus Vaccine (H1N1) Distributors List
8.3 Influenza Virus Vaccine (H1N1) Customers
9 Influenza Virus Vaccine (H1N1) Market Dynamics
9.1 Influenza Virus Vaccine (H1N1) Industry Trends
9.2 Influenza Virus Vaccine (H1N1) Market Drivers
9.3 Influenza Virus Vaccine (H1N1) Market Challenges
9.4 Influenza Virus Vaccine (H1N1) Market Restraints
10 Global Market Forecast
10.1 Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Influenza Virus Vaccine (H1N1) by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Influenza Virus Vaccine (H1N1) by Type (2023-2028)
10.2 Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Influenza Virus Vaccine (H1N1) by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Influenza Virus Vaccine (H1N1) by Application (2023-2028)
10.3 Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Influenza Virus Vaccine (H1N1) by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Influenza Virus Vaccine (H1N1) by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Influenza Virus Vaccine (H1N1) Sales Growth Rate Comparison by Type (2022-2028) & (K Doses) & (US$ Million)
Table 2. Global Influenza Virus Vaccine (H1N1) Sales Growth Rate Comparison by Application (2022-2028) & (K Doses) & (US$ Million)
Table 3. Global Influenza Virus Vaccine (H1N1) Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Influenza Virus Vaccine (H1N1) Market Competitive Situation by Manufacturers in 2021
Table 5. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) of Key Manufacturers (2017-2022)
Table 6. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Influenza Virus Vaccine (H1N1) Average Price (US$/Dose) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Influenza Virus Vaccine (H1N1) Manufacturing Sites and Area Served
Table 11. Manufacturers Influenza Virus Vaccine (H1N1) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Influenza Virus Vaccine (H1N1) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Influenza Virus Vaccine (H1N1) Sales by Region (2017-2022) & (K Doses)
Table 16. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2017-2022)
Table 17. Global Influenza Virus Vaccine (H1N1) Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2017-2022)
Table 19. North America Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022) & (K Doses)
Table 20. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2017-2022)
Table 21. North America Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2017-2022)
Table 23. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022) & (K Doses)
Table 24. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2017-2022)
Table 25. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2017-2022) & (K Doses)
Table 28. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2017-2022)
Table 31. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022) & (K Doses)
Table 32. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2017-2022)
Table 33. Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022) & (K Doses)
Table 36. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2017-2022)
Table 39. Global Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)
Table 40. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2022)
Table 41. Global Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Influenza Virus Vaccine (H1N1) Revenue Share by Type (2017-2022)
Table 43. Global Influenza Virus Vaccine (H1N1) Price by Type (2017-2022) & (US$/Dose)
Table 44. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Application (2017-2022)
Table 45. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2022)
Table 46. Global Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Influenza Virus Vaccine (H1N1) Revenue Share by Application (2017-2022)
Table 48. Global Influenza Virus Vaccine (H1N1) Price by Application (2017-2022) & (US$/Dose)
Table 49. CSL Corporation Information
Table 50. CSL Description and Business Overview
Table 51. CSL Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 52. CSL Influenza Virus Vaccine (H1N1) Product
Table 53. CSL Recent Developments/Updates
Table 54. NVS(Novartis) Corporation Information
Table 55. NVS(Novartis) Description and Business Overview
Table 56. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 57. NVS(Novartis) Influenza Virus Vaccine (H1N1) Product
Table 58. NVS(Novartis) Recent Developments/Updates
Table 59. Sanofi Pasteur Corporation Information
Table 60. Sanofi Pasteur Description and Business Overview
Table 61. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 62. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product
Table 63. Sanofi Pasteur Recent Developments/Updates
Table 64. Medimmune Corporation Information
Table 65. Medimmune Description and Business Overview
Table 66. Medimmune Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 67. Medimmune Influenza Virus Vaccine (H1N1) Product
Table 68. Medimmune Recent Developments/Updates
Table 69. GSK Corporation Information
Table 70. GSK Description and Business Overview
Table 71. GSK Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 72. GSK Influenza Virus Vaccine (H1N1) Product
Table 73. GSK Recent Developments/Updates
Table 74. Baxter Corporation Information
Table 75. Baxter Description and Business Overview
Table 76. Baxter Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 77. Baxter Influenza Virus Vaccine (H1N1) Product
Table 78. Baxter Recent Developments/Updates
Table 79. Beijing Kexing Bio-Vaccine Corporation Information
Table 80. Beijing Kexing Bio-Vaccine Description and Business Overview
Table 81. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 82. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product
Table 83. Beijing Kexing Bio-Vaccine Recent Developments/Updates
Table 84. Hualan Bio-Vaccine Corporation Information
Table 85. Hualan Bio-Vaccine Description and Business Overview
Table 86. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 87. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product
Table 88. Hualan Bio-Vaccine Recent Developments/Updates
Table 89. Changchun Changsheng Bio-Technology Corporation Information
Table 90. Changchun Changsheng Bio-Technology Description and Business Overview
Table 91. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 92. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product
Table 93. Changchun Changsheng Bio-Technology Recent Developments/Updates
Table 94. Beijing Tiantan Bio-Products Corporation Information
Table 95. Beijing Tiantan Bio-Products Description and Business Overview
Table 96. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 97. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product
Table 98. Beijing Tiantan Bio-Products Recent Developments/Updates
Table 99. Jiangsu Yanshen Bio-Technology Corporation Information
Table 100. Jiangsu Yanshen Bio-Technology Description and Business Overview
Table 101. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 102. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product
Table 103. Jiangsu Yanshen Bio-Technology Recent Developments/Updates
Table 104. Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
Table 105. Zhejiang Tianyuan Bio-Pharmaceutical Description and Business Overview
Table 106. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 107. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product
Table 108. Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments/Updates
Table 109. Dalian Yalifeng Bio-Pharmaceutical Corporation Information
Table 110. Dalian Yalifeng Bio-Pharmaceutical Description and Business Overview
Table 111. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 112. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product
Table 113. Dalian Yalifeng Bio-Pharmaceutical Recent Developments/Updates
Table 114. Sinopharm Corporation Information
Table 115. Sinopharm Description and Business Overview
Table 116. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 117. Sinopharm Influenza Virus Vaccine (H1N1) Product
Table 118. Sinopharm Recent Developments/Updates
Table 119. Production Base and Market Concentration Rate of Raw Material
Table 120. Key Suppliers of Raw Materials
Table 121. Influenza Virus Vaccine (H1N1) Distributors List
Table 122. Influenza Virus Vaccine (H1N1) Customers List
Table 123. Influenza Virus Vaccine (H1N1) Market Trends
Table 124. Influenza Virus Vaccine (H1N1) Market Drivers
Table 125. Influenza Virus Vaccine (H1N1) Market Challenges
Table 126. Influenza Virus Vaccine (H1N1) Market Restraints
Table 127. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2023-2028) & (K Doses)
Table 128. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Type (2023-2028)
Table 129. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 130. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Type (2023-2028)
Table 131. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2023-2028) & (K Doses)
Table 132. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Application (2023-2028)
Table 133. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 134. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Application (2023-2028)
Table 135. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2023-2028) & (K Doses)
Table 136. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Region (2023-2028)
Table 137. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 138. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Region (2023-2028)
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Influenza Virus Vaccine (H1N1)
Figure 2. Global Influenza Virus Vaccine (H1N1) Market Share by Type in 2021 & 2028
Figure 3. Intramuscular Vaccine Product Picture
Figure 4. Nasal Spray Vaccine Product Picture
Figure 5. Global Influenza Virus Vaccine (H1N1) Market Share by Application in 2021 & 2028
Figure 6. 3 To 10 Years Old
Figure 7. 10 To 18 Years Old
Figure 8. Above 18 Years Old
Figure 9. Other
Figure 10. Global Influenza Virus Vaccine (H1N1) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Influenza Virus Vaccine (H1N1) Market Size (2017-2028) & (US$ Million)
Figure 12. Global Influenza Virus Vaccine (H1N1) Sales (2017-2028) & (K Doses)
Figure 13. Influenza Virus Vaccine (H1N1) Sales Share by Manufacturers in 2021
Figure 14. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Influenza Virus Vaccine (H1N1) Players: Market Share by Revenue in 2021
Figure 16. Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2017-2022)
Figure 18. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region in 2021
Figure 19. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2017-2022)
Figure 20. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region in 2021
Figure 21. U.S. Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Taiwan Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Philippines Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Vietnam Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Mexico Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Brazil Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Argentina Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Influenza Virus Vaccine (H1N1) by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Influenza Virus Vaccine (H1N1)
Figure 47. Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1)
Figure 48. Influenza Virus Vaccine (H1N1) Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
  • Global Megestrol Acetate (Megace) Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 96
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Suspension - Tablets Segment by Application - Hospital - Clinic - Other ......
  • Global Oxcarbazepine Tablets Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 116
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Tablets (150mg) - Tablets (300mg) - Tablets (600mg) Segment by Application - Hospital......
  • Global Oxcarbazepine API Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 116
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Medical Grade - Other Segment by Application - Tablets - Oral Suspension - Oth......
  • Global Therapeutic Dog Food Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 100
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Dry Food - Wet/Canned Food - Fresh Food - Snacks/treats - Others Segment by Ap......
  • Global Transtympanic Injectable Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 90
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Corticosteroid - Aminoglycosides Segment by Application - Hospitals - ENT Clinics......
  • Global Enzyme Indicators Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 119
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Bio-decontamination - Drug Development - Pesticide Synthesis Segment by Application -......
  • Global Stool Softeners Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 102
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Liquid - Softgel Capsule - Enema Segment by Application - Hospitals - Clinics......
  • Global Std Self Diagnostics Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 94
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Testing Kit - Testing Device - Testing Strip/chip Segment by Application - Hospitals......
  • Global Eye Drops for Contact Lens Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - = 10ml - > 10ml Segment by Application - Online Channel - Offline Channel ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs